$IGXT
IntelGenx Technologies Corp. Stock $igxt

$igxt Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000106299321010611 Filed on November 12, 2021

Income Statement

Concept	2021 Q3	2020 Q3
Revenue	$593.0K	$510.0K
YoY Change	16.27%	736.07%
Cost Of Revenue	$499.0K
YoY Change
Gross Profit	$94.00K
YoY Change
Gross Profit Margin	15.85%
Selling, General & Admin	$662.0K	$870.0K
YoY Change	-23.91%	-44.23%
% of Gross Profit	704.26%
Research & Development	$874.0K	$850.0K
YoY Change	2.82%	0.95%
% of Gross Profit	929.79%
Depreciation & Amortization	$199.0K	$190.0K
YoY Change	4.74%	5.56%
% of Gross Profit	211.7%
Operating Expenses	$1.735M	$1.900M
YoY Change	-8.68%	-26.41%
Operating Profit	-$1.641M
YoY Change
Interest Expense	$365.0K	$274.0K
YoY Change	33.21%	-10.16%
% of Operating Profit
Other Income/Expense, Net	-$364.0K	-$271.0K
YoY Change	34.32%	-5.24%
Pretax Income	-$2.005M	-$1.660M
YoY Change	20.78%	-40.93%
Income Tax	-$3.000K
% Of Pretax Income
Net Earnings	-$2.002M	-$1.660M
YoY Change	20.6%	-40.86%
Net Earnings / Revenue	-337.61%	-325.49%
Basic Earnings Per Share	-$0.01
Diluted Earnings Per Share	-$13.29K	-$0.02
COMMON SHARES
Basic Shares Outstanding	150.6M shares
Diluted Shares Outstanding	150.6M shares

Balance Sheet

Concept	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.03M	$1.530M
YoY Change	686.41%	-64.34%
Cash & Equivalents	$6.019M	$1.531M
Short-Term Investments	$6.013M	$1.190M
Other Short-Term Assets	$320.0K	$200.0K
YoY Change	60.0%	11.11%
Inventory	$68.00K	$280.0K
Prepaid Expenses
Receivables	$1.162M	$980.0K
Other Receivables	$407.0K	$510.0K
Total Short-Term Assets	$13.99M	$3.500M
YoY Change	299.69%	-34.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.398M	$6.360M
YoY Change	0.6%	-9.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$252.0K	$740.0K
YoY Change	-65.95%	1.37%
Total Long-Term Assets	$6.650M	$7.090M
YoY Change	-6.21%	-8.28%
TOTAL ASSETS
Total Short-Term Assets	$13.99M	$3.500M
Total Long-Term Assets	$6.650M	$7.090M
Total Assets	$20.64M	$10.59M
YoY Change	94.89%	-18.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.304M	$2.210M
YoY Change	4.25%	27.75%
Accrued Expenses	$248.0K	$130.0K
YoY Change	90.77%	-7.14%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$1.420M
YoY Change	-100.0%
Long-Term Debt Due	$0.00	$700.0K
YoY Change	-100.0%	-1.82%
Total Short-Term Liabilities	$8.096M	$4.670M
YoY Change	73.36%	81.22%
LONG-TERM LIABILITIES
Long-Term Debt	$6.557M	$5.540M
YoY Change	18.36%	766.98%
Other Long-Term Liabilities	$691.0K	$480.0K
YoY Change	43.96%	-14.29%
Total Long-Term Liabilities	$7.248M	$6.020M
YoY Change	20.4%	842.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.096M	$4.670M
Total Long-Term Liabilities	$7.248M	$6.020M
Total Liabilities	$15.43M	$10.68M
YoY Change	44.44%	232.09%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.213M	-$87.00K
YoY Change
Total Liabilities & Shareholders Equity	$20.64M	$10.59M
YoY Change	94.89%	-18.97%

Cashflow Statement

Concept	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	-$2.002M	-$1.660M
YoY Change	20.6%	-40.86%
Depreciation, Depletion And Amortization	$199.0K	$190.0K
YoY Change	4.74%	5.56%
Cash From Operating Activities	-$1.723M	-$1.550M
YoY Change	11.16%	9.85%
INVESTING ACTIVITIES
Capital Expenditures	-$58.00K	$20.00K
YoY Change	-390.0%	-89.3%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$1.870M
YoY Change	-100.0%
Cash From Investing Activities	-$58.00K	$1.850M
YoY Change	-103.14%	-1122.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$0.00
YoY Change
Debt Paid & Issued, Net	$0.00
YoY Change
Cash From Financing Activities	1.852M	-60.00K
YoY Change	-3186.67%	-69.39%
NET CHANGE
Cash From Operating Activities	-1.723M	-1.550M
Cash From Investing Activities	-$58.00K	1.850M
Cash From Financing Activities	1.852M	-60.00K
Net Change In Cash	-$58.00K	240.0K
YoY Change	-124.17%	-113.42%
FREE CASH FLOW
Cash From Operating Activities	-$1.723M	-$1.550M
Capital Expenditures	-$58.00K	$20.00K
Free Cash Flow	-$1.665M	-$1.570M
YoY Change	6.05%	-1.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	USD
CY2020Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1486000	USD
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2021Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2021Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	USD
	igxt	Agents Warrants Issued During Period AgentsWarrantsIssuedDuringPeriod	164000	USD
	igxt	Stock Issued During Period Value Conversion Of Convertible Notes StockIssuedDuringPeriodValueConversionOfConvertibleNotes	321000	USD
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	325000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	5213000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	152000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	405000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	365000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	274000	USD
	us-gaap	Interest Expense InterestExpense	1134000	USD
	us-gaap	Interest Expense InterestExpense	881000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-982000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2005000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1660000	USD
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	150627761	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	150627761	shares
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1641000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	110259652	shares
CY2021Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-953000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8398000	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3526000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1041000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	754000	USD
	us-gaap	Revenues Revenues	1041000	USD
	us-gaap	Revenues Revenues	754000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1910000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2300000	USD
	us-gaap	Manufacturing Costs ManufacturingCosts	1598000	USD
	us-gaap	Manufacturing Costs ManufacturingCosts	1042000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2419000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2167000	USD
	us-gaap	Depreciation Depreciation	589000	USD
	us-gaap	Depreciation Depreciation	536000	USD
	us-gaap	Operating Expenses OperatingExpenses	6516000	USD
	us-gaap	Operating Expenses OperatingExpenses	6045000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5475000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5291000	USD
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000	USD
CY2021Q3	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2021Q3	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-173000	USD
CY2020Q3	us-gaap	Repayments Of Debt RepaymentsOfDebt	59000	USD
CY2021Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-58000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-476000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6454000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5767000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-518000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-108000	USD
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	2000	USD
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	79000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-516000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-29000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6970000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5796000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	150590729	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	131576774	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	107818057	shares
	us-gaap	Depreciation Depreciation	536000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	81000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	172000	USD
	us-gaap	Accretion Expense AccretionExpense	370000	USD
	us-gaap	Accretion Expense AccretionExpense	407000	USD
	igxt	Dsu Expenses DsuExpenses	345000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
	us-gaap	Net Income Loss NetIncomeLoss	-6454000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5767000	USD
	us-gaap	Depreciation Depreciation	589000	USD
	igxt	Dsu Expenses DsuExpenses	-182000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	151000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	401000	USD
	igxt	Lease Expense LeaseExpense	15000	USD
	igxt	Lease Expense LeaseExpense	-3000	USD
	igxt	Total Adjustments TotalAdjustments	-5208000	USD
	igxt	Total Adjustments TotalAdjustments	-5238000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	902000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	598000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-50000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	27000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-228000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	140000	USD
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-354000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-176000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-93000	USD
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	206000	USD
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-5000	USD
CY2020Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	222000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-24000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	463000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	27000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	195000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-115000	USD
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	19000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5093000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5257000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6457000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12346000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5564000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	422000	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	29000	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	69000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15500000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4998000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	80000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	98000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1034000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	3899000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	6000000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	4532000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5046000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-731000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5361000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-990000	USD
CY2020Q3	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-40000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-547000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-5000	USD
CY2021Q2	us-gaap	Cash Cash	6121000	USD
CY2020Q2	us-gaap	Cash Cash	134000	USD
CY2020Q4	us-gaap	Cash Cash	1205000	USD
CY2019Q4	us-gaap	Cash Cash	1332000	USD
CY2021Q3	us-gaap	Cash Cash	6019000	USD
CY2020Q3	us-gaap	Cash Cash	337000	USD
CY2021Q3	us-gaap	Cash Cash	6019000	USD
CY2020Q3	us-gaap	Cash Cash	337000	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5767000	USD
CY2021Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3000	USD
CY2020Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-0	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3000	USD
CY2020Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-0	USD
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-0	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	737000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	177000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2500000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	21000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2020Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	320000	USD
CY2021Q3	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2020Q3	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2021Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1897000	USD
CY2020Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1897000	USD
CY2020Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2021Q3	igxt	Payments For Repurchase Of Convertible Notes PaymentsForRepurchaseOfConvertibleNotes	34000	USD
CY2020Q3	igxt	Payments For Repurchase Of Convertible Notes PaymentsForRepurchaseOfConvertibleNotes	0	USD
	igxt	Payments For Repurchase Of Convertible Notes PaymentsForRepurchaseOfConvertibleNotes	34000	USD
CY2020Q3	igxt	Payments For Repurchase Of Convertible Notes PaymentsForRepurchaseOfConvertibleNotes	0	USD
CY2017Q3	igxt	Proceeds From Convertible Debt Amount Per Instrument ProceedsFromConvertibleDebtAmountPerInstrument	1000	CAD
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	150627761	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	111429532	shares
CY2017Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5367000	USD
CY2018Q2	igxt	Convertible Debt Issued In Units ConvertibleDebtIssuedInUnits	5000	USD
CY2018Q2	igxt	Interest Rate On Convertible Note InterestRateOnConvertibleNote	0.06	pure
CY2018Q2	igxt	Interest Rate On Convertible Note InterestRateOnConvertibleNote	0.06	pure
CY2018Q2	igxt	Warrants Issued During Period Warrants WarrantsIssuedDuringPeriodWarrants	7690	shares
CY2021Q2	igxt	Interest Rate On Convertible Note InterestRateOnConvertibleNote	0.08	pure
CY2018Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.80
CY2018Q2	igxt	Interest Rate On Convertible Note InterestRateOnConvertibleNote	0.06	pure
CY2021Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.44
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	151000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	81000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	10000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	172000	USD
CY2021Q3	igxt	Transaction Price Allocated To Remaining Per Formance Obligation TransactionPriceAllocatedToRemainingPerFormanceObligation	1608000	USD
CY2021Q3	igxt	Research And Development Milestone Payments ResearchAndDevelopmentMilestonePayments	2557000	USD
	igxt	Percentages Of Recognized In Next Three Year PercentagesOfRecognizedInNextThreeYear	1	pure
CY2021Q3	igxt	Commercial Sales Milestone Payments CommercialSalesMilestonePayments	433000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	77000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	272000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	276000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	284000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	284000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	43000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	43000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	40000	USD
CY2021Q3	us-gaap	Other Long Term Debt OtherLongTermDebt	0	USD
CY2020Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	732000	USD
CY2017Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	6838000	CAD
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	47000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	6000	USD

Files In Submission

Name	View Source	Status
0001062993-21-010611-index-headers.html	Edgar Link	pending
0001062993-21-010611-index.html	Edgar Link	pending
0001062993-21-010611.txt	Edgar Link	pending
0001062993-21-010611-xbrl.zip	Edgar Link	pending
exhibit31-1.htm	Edgar Link	pending
exhibit31-2.htm	Edgar Link	pending
exhibit32-1.htm	Edgar Link	pending
exhibit32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10q.htm	Edgar Link	pending
form10q_htm.xml	Edgar Link	completed
igxt-20210930.xsd	Edgar Link	pending
igxt-20210930_cal.xml	Edgar Link	unprocessable
igxt-20210930_def.xml	Edgar Link	unprocessable
igxt-20210930_lab.xml	Edgar Link	unprocessable
igxt-20210930_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IGXT
IntelGenx Technologies Corp. Stock $igxt

2021 Q3 Form 10-Q Financial Statement

#000106299321010611 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IGXT IntelGenx Technologies Corp. Stock $igxt

2021 Q3 Form 10-Q Financial Statement

#000106299321010611 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IGXT
IntelGenx Technologies Corp. Stock $igxt